Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. Revolution Medicines is seeking an initiative-taking and exceptional Executive Director of Finance to join our growing Finance team. The Executive Director of Finance will play a key role in managing the company's accounting operations, ensuring compliance with US GAAP, supporting SEC reporting, SOX 404b compliance and driving process improvements as the company prepares for commercial launch and scale globally. This position offers the opportunity to work in a fast-paced biotech environment and contribute to the financial success of a mission-driven organization. This role reports to the VP Finance, Controller.